Marc Leighton Turner

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada.

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom.

PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom.

The Heart Hospital Ltd. provides specialised cardiac healthcare services. The company is based in London, UK and ultimately controlled by the Government of United Kingdom. The Heart Hospital was acquired by National Health Service from Parkway Holdings Ltd. on August 08, 2001 for $38.97 million.

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.

Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.

The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom.

Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom.

Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay.

BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom.

The Royal Society of Edinburgh provides investment advice. The non-profit company is based in Edinburgh, UK and has subsidiaries in the United Kingdom.

The Parkinson's Disease Society of the United Kingdom is a non-profit organization that aims to support research on Parkinson's disease. The non-profit company is based in London, UK. The British company provides health information about Parkinson's for patients, caregivers, and family members. The organization also supports researchers to involve patients and the public in their work. The company offers a Parkinson's Learning Pathway for occupational therapists, physiotherapists, and speech and language therapists. The company was founded in 1969 by Mali Jenkins. Caroline Rassell has been the CEO of the company since 2021.

Picker Institute Europe provides health and social care services. The non-profit company is based in Oxford, UK. The British company was founded in 2000. Chris Graham has been the CEO of the company since 2011.

Cell Therapy Catapult Services Ltd. offers gene therapy services. The private company is based in London, UK.

NHS England provides primary and mental health care services and is ultimately controlled by the Government of United Kingdom. The company is based in Redditch, UK. The CEO of the British company is Amanda Pritchard.

BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom.

Lizard Bioconsulting Ltd. provides management consultancy services. The private company is based in Cambridge, UK. The British company was founded in 2013 by Nick Higgins.

The European Association for Cardio-Thoracic Surgery was founded in 1986 and is based in Windsor, UK. The British company represents over 4,000 surgeons and aims to advance education in the field of cardiac, thoracic, and vascular interventions. The private company also promotes and disseminate research into cardiovascular and thoracic physiology, pathology, and therapy.

The Society for Cardiothoracic Surgery in Great Britain & Ireland is a professional organization related to cardiac surgery. The non-profit company is based in Great Britain and Ireland.

Birmingham Women's NHS Foundation Trust provides health care services. The non-profit company is based in Edgbaston, UK.

FutureNova Ltd. develops products for private and public healthcare professionals. The company was founded by Mike Casey in 2013 and is headquartered in Chelmsford, the United Kingdom.

Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom.

LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.

Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples.

Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom.

Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then.

Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables.

Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany.